Retrospective evaluation of therapies for Staphylococcus aureus endocarditis

Pharmacotherapy

Volumn 17, Issue 5 I, 1997, Pages 990-997

  Gentry, Chris A ^a   Rodvold, Keith A ^a   Novak, Richard M ^a   Hershow, Ronald C ^a   Naderer, Odin J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; NAFCILLIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEMATOCRIT; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; NAFCILLIN; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 0030801977     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995;274:1706-13.
2. Karchmer AW. Staphylococcal endocarditis. In: Kaye D, ed. Infective endocarditis, 2nd ed. New York: Raven Press, 1992:225-49.
3. Bayer AS. Infective endocarditis. Clin Infect Dis 1993;17:313-22.
4. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990;34:1227-31.
5. Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982;97:330-8.
6. Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 1986;8:374-96.
7. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991;115:674-80.
8. Durack DT, Lukes AS, Bright DK, et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96:200-9.
9. Tuazon CU, Cardella TA, Sheagren JN. Staphylococcal endocarditis in drug users. Arch Intern Med 1975;135:1555-61.
10. Abrams B, Sklaver A, Hoffman T, Greenman R. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med 1979;90:789-91.
11. Parker RH, Fossieck BE. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. Ann Intern Med 1980;93:832-4.
12. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts. Ann Intern Med 1982;97:496-503.
13. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988;109: 619-24.
14. Gopal V, Bisno AL, Silverblatt FJ. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. JAMA 1976;236:1604-6.
15. Jackson MA, Hicks RA. Vancomycin failure in staphylococcal endocarditis. Pediatr Infect Dis J 1987;6:750-2.
16. Stratton CW, Liu C, Weeks LS. Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob Agents Chemother 1987;31:1210-15.
17. Cantoni L, Wenger A, Glauser MP, Bille J. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J Infect Dis 1989;159:989-93.
18. Cantoni L, Glauser MP, Bille J. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination. Antimicrob Agents and Chemother 1990;34:2348-53.
19. Wood CA, Wisniewski RM. β-Lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. Antimicrob Agents Chemother 1994;38:1023-6.